Companies

ALX ONCOLOGY HOLDINGS INC (ALXO) SEC filings

CIK 0001810182 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)0
Net income (USD)-123.5 M-83.5 M-45.7 M
Diluted EPS (USD/shares)-1.9-3.03

Latest filings

FiledFormDescriptionPeriod
2026-10-16SCHEDULE 13D/ASCHEDULE 13D/A
2026-10-158-K8-K items 1.01,3.02,9.012026-10-14
2026-08-18442026-08-17
2026-08-18442026-08-17
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-07-27SCHEDULE 13GSCHEDULE 13G
2026-07-06442026-07-01
2026-06-308-K8-K items 5.02,7.01,8.01,9.012026-06-29
2026-06-268-K8-K items 1.01,1.02,2.03,9.012026-06-25
2026-06-118-K8-K items 5.072026-06-10
2026-05-27SCHEDULE 13D/ASCHEDULE 13D/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-0810-Q10-Q2026-03-31
2026-05-088-K8-K items 2.02,9.012026-05-08
2026-04-28SCHEDULE 13G/ASCHEDULE 13G/A
2026-04-20ARSARS2025-12-31
2026-04-20DEF 14ADEF 14A2026-04-17
2026-04-17442026-04-16
2026-04-17442026-04-16
2026-04-17332026-04-13
2026-04-138-K8-K items 5.02,7.01,9.012026-04-13
2026-03-23442026-03-19

Forms on file (last 1,000): 4 187, 8-K 64, 3 23, 10-Q 19, SCHEDULE 13G/A 12, SC 13G/A 12, CORRESP 9, SC 13G 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ALXO (0.002 USD), /gw/filings/filings?ticker=ALXO&form=8-K, /gw/filings/facts?ticker=ALXO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange